Inspire Medical Systems Reports Q1 2026 Earnings Amid Reimbursement Challenges
Inspire Medical Systems (INSP) reported lower-than-expected Q1 revenue due to reimbursement uncertainty and procedural delays from the WISER Medicare pilot program. The company revised its full-year guidance, anticipating a $120 million to $150 million impact with significant effects in Q2 before expecting sequential growth later in 2026.
Tickers: $INSP
Topics: coding_reimbursement_challenges medical_devices operational_strategy